A detailed history of Black Rock Inc. transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Black Rock Inc. holds 497,696 shares of VOR stock, worth $432,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares
497,696
Previous 2,247,458 77.86%
Holding current value
$432,995
Previous $5.33 Million 90.67%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.0 - $2.2 $1.75 Million - $3.85 Million
-1,749,762 Reduced 77.86%
497,696 $497,000
Q1 2024

May 10, 2024

SELL
$1.8 - $2.85 $7,115 - $11,266
-3,953 Reduced 0.18%
2,247,458 $5.33 Million
Q4 2023

Feb 13, 2024

BUY
$1.66 - $2.63 $239,939 - $380,145
144,542 Added 6.86%
2,251,411 $5.07 Million
Q3 2023

Nov 13, 2023

SELL
$2.1 - $3.35 $121,512 - $193,841
-57,863 Reduced 2.67%
2,106,869 $4.47 Million
Q2 2023

Aug 11, 2023

BUY
$3.09 - $5.33 $5.24 Million - $9.05 Million
1,697,134 Added 362.95%
2,164,732 $6.69 Million
Q1 2023

May 12, 2023

BUY
$4.68 - $6.96 $1.08 Million - $1.6 Million
230,327 Added 97.07%
467,598 $2.52 Million
Q4 2022

Feb 13, 2023

SELL
$3.77 - $7.43 $755,319 - $1.49 Million
-200,350 Reduced 45.78%
237,271 $1.58 Million
Q3 2022

Nov 14, 2022

SELL
$3.9 - $5.52 $9,738 - $13,783
-2,497 Reduced 0.57%
437,621 $1.74 Million
Q2 2022

Aug 12, 2022

SELL
$3.89 - $6.44 $3.54 Million - $5.85 Million
-909,127 Reduced 67.38%
440,118 $2.19 Million
Q1 2022

May 12, 2022

SELL
$6.04 - $12.23 $326,655 - $661,422
-54,082 Reduced 3.85%
1,349,245 $8.15 Million
Q4 2021

Feb 10, 2022

BUY
$11.32 - $18.02 $3.09 Million - $4.92 Million
273,289 Added 24.18%
1,403,327 $16.3 Million
Q3 2021

Nov 09, 2021

BUY
$12.24 - $20.38 $4.36 Million - $7.26 Million
356,413 Added 46.07%
1,130,038 $17.7 Million
Q2 2021

Aug 11, 2021

BUY
$18.65 - $38.78 $14.4 Million - $30 Million
773,625 New
773,625 $14.4 Million

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $33.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.